Register update: there will be a delay adding new records during our holiday period (July-Aug)
Cochrane COVID-19 Study Register
AboutHelp
Back to Search Results
Study record
Bajaj 2021First Published: 2021 Jan 13Updated Date: 2021 Jan 13

Cirrhosis is associated with high mortality and readmissions over 90 days regardless of COVID-19: a multi-center cohort

  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Epidemiology
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
Reference record

Cirrhosis is associated with high mortality and readmissions over 90 days regardless of COVID-19: a multi-center cohort

Bajaj JS, Garcia-Tsao G, Wong F, Biggins SW, Kamath PS, McGeorge S, Chew M, Pearson M, Shaw J, Kalluri A, Fagan A, Olofson A, Moini M, De La Rodriguez R, Reddy KR
First Published Liver Transplantation (https://pubmed.ncbi.nlm.nih.gov/33427401)
Journal article
Report Results
The short-term prognosis of COVID-19 is impacted by underlying cirrhosis and other comorbidities(1). However, as shown in our multicenter study, inpatient mortality was similar in patients with cirrhosis+COVID-19 and cirrhosis without COVID-19, but was higher than a contemporaneous cohort of hospitalized patients with COVID-19 without cirrhosis(2). We herein describe the 90-day post-discharge outcomes in that age and gender-matched cohort of patients admitted with cirrhosis+COVID-19, cirrhosis alone, and COVID-19 alone